Literature DB >> 16493203

The prevalence of Parkinson's disease in an area of North Tyneside in the North-East of England.

Bob Porter1, Rob Macfarlane, Nigel Unwin, Richard Walker.   

Abstract

OBJECTIVES: UK prevalence studies have demonstrated prevalence rates for Parkinson's disease (PD) of 108 to 164 cases per 100,000. we aimed to calculate the prevalence of PD in an area of the North-East of England.
MATERIAL AND METHODS: A case finding methodology was used to identify cases in North Tyneside with a population of 108,597 at the 2001 UK census.
RESULTS: 161 cases were identified giving crude and age-adjusted prevalence estimates of 148 cases (95% CI 124-174) and 139 cases (95% CI 116-162) per 100,000, respectively. The mean age was 74.1 years (range 44-96 years) with mean disease duration of 5.6 years.
CONCLUSIONS: The prevalence of PD in North Tyneside is comparable with that of the rest of the UK. The prevalence of PD in the UK appears not to have changed greatly over the last 30 years.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493203     DOI: 10.1159/000091657

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  10 in total

1.  Is Parkinson's disease-related mortality declining?

Authors:  E Haberfeld; E D Louis
Journal:  Eur J Neurol       Date:  2009-06-30       Impact factor: 6.089

2.  Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

Authors:  Caroline H Williams-Gray; An Goris; Misuzu Saiki; Thomas Foltynie; D Alastair S Compston; Stephen J Sawcer; Roger A Barker
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

3.  A cross-sectional study of the nutritional status of community-dwelling people with idiopathic Parkinson's disease.

Authors:  Ahmed F Jaafar; William K Gray; Bob Porter; Elizabeth J Turnbull; Richard W Walker
Journal:  BMC Neurol       Date:  2010-12-30       Impact factor: 2.474

Review 4.  Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.

Authors:  Dénes Zádori; Péter Klivényi; Imola Plangár; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

5.  The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease.

Authors:  Simon Eggington; Francesc Valldeoriola; K Ray Chaudhuri; Keyoumars Ashkan; Elena Annoni; Günther Deuschl
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

6.  Remarkably Few Sputum Cultures from People with Parkinson's Disease during Hospital In-Patient Admission.

Authors:  Richard W Walker; Joel English; Grace Tan; Annette Fisher; William K Gray
Journal:  Parkinsons Dis       Date:  2015-02-05

7.  The rise of mortality from mental and neurological diseases in Europe, 1979-2009: observational study.

Authors:  Johan P Mackenbach; Marina Karanikolos; Caspar W N Looman
Journal:  BMC Public Health       Date:  2014-08-13       Impact factor: 3.295

8.  Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset.

Authors:  Kimberley J Billingsley; Ines A Barbosa; Mina Ryten; Sulev Koks; Sara Bandrés-Ciga; John P Quinn; Vivien J Bubb; Charu Deshpande; Juan A Botia; Regina H Reynolds; David Zhang; Michael A Simpson; Cornelis Blauwendraat; Ziv Gan-Or; J Raphael Gibbs; Mike A Nalls; Andrew Singleton
Journal:  NPJ Parkinsons Dis       Date:  2019-05-22

9.  Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.

Authors:  Margaux F Keller; Mohamad Saad; Jose Bras; Francesco Bettella; Nayia Nicolaou; Javier Simón-Sánchez; Florian Mittag; Finja Büchel; Manu Sharma; J Raphael Gibbs; Claudia Schulte; Valentina Moskvina; Alexandra Durr; Peter Holmans; Laura L Kilarski; Rita Guerreiro; Dena G Hernandez; Alexis Brice; Pauli Ylikotila; Hreinn Stefánsson; Kari Majamaa; Huw R Morris; Nigel Williams; Thomas Gasser; Peter Heutink; Nicholas W Wood; John Hardy; Maria Martinez; Andrew B Singleton; Michael A Nalls
Journal:  Hum Mol Genet       Date:  2012-08-13       Impact factor: 6.150

10.  Towards accurate and unbiased imaging-based differentiation of Parkinson's disease, progressive supranuclear palsy and corticobasal syndrome.

Authors:  Marta M Correia; Timothy Rittman; Christopher L Barnes; Ian T Coyle-Gilchrist; Boyd Ghosh; Laura E Hughes; James B Rowe
Journal:  Brain Commun       Date:  2020-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.